Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France

Neurology

Volumn 47, Issue 3, 1996, Pages 690-695

  Billette De Villemeur, T ^a   Deslys, J P ^b   Pradel, A ^c   Soubrie G ^a   Alperovitch A ^a   Tardieu, M ^a,d   Chaussain, J L ^a   Hauw, J J ^a   Dormont, D ^a   Ruberg, M ^c   Agid, Y ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; ARTICLE; ATAXIA; BRAIN SPONGIOSIS; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; FRANCE; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; NEUROLOGICAL COMPLICATION; NYSTAGMUS; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

EID: 0001699149     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.3.690     Document Type: Article

References (51)

1. Prusiner SB, Hsiao KK. Human prion disease. Ann Neurol 1994;35:385-395.
2. Gibbs CJ, Gajdusek DC, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to chimpanzee. Science 1968;161:389-390.
3. Brown P, Preece MA, Will RG. 'Friendly fire' in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992;340:24-27.
4. Duffy P, Wolf J, Collins G, De Voe AG, Streeten B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-693.
5. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft: case report. J Neurosurg 1988;69:766-769.
6. Nisbet TJ, McDonaldson I, Bishara SN. Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. JAMA 1989;261:11-18.
7. Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA. Transmission of Creutzfeldt-Jakob disease by durai cadaveric graft. J Neurosurg 1989;71:954-955.
8. Miyashita K, Inuzuka T, Hondo H, et al. Creutzfeldt-Jakob disease in a patient with a cadaveric durai graft. Neurology 1991;41:940-941.
9. Willison HJ, Gale HN, McLaughlin JE. Creutzfeldt-Jakob disease following cadaveric dura mater graft [letter]. J Neurol Neurosurg Psychiatry 1991;54:940.
10. Pocchiari M, Masullo C, Salvatore M, Genuardi M, Galgani S. Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet 1992;340:614-615.
11. Esmonde T, Lueck CJ, Symon L, Ducken LW, Will RG. Creutzfeldt-Jakob disease and lyophilized dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry 1993;56: 999-1000.
12. Martinez-Lage JF, Poza M, Sola J, et al. Accidental transmission of Creutzfeldt-Jakob disease by durai cadaveric graft. J Neurol Neurosurg Psychiatry 1994;57:1091-1094.
13. Takayama S, Hatsuda N, Matsumura K, Nakasu S, Handa J. Creutzfeldt-Jakob disease transmitted by cadaveric durai graft: a case report. No Shinkei Geka 1993;21:167-170.
14. Lane KL, Brown P, Howell DN, et al. Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 1994;34:737-740.
15. Yamada S, Aiba T, Endo Y, Kara M, Kitamoto T, Tateishi J. Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft. Neurosurgery 1994;34:740-744.
16. Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;2: 244-246.
17. Koch TK, Berg BO, de Armond SJ, Gravina RF. CreutzfeldtJakob disease in a young adult with idiopathic hypopituitarism: possible relation to the administration of cadaveric human growth hormone. N Engl J Med 1985;313:731-733.
18. Gibbs CJ, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone? N Engl J Med 1985;313:734-738.
19. Tintner R, Brown P, Hedley-Whyte T, Rappaport EB, Piccardo CP, Gajdusek DC. Neuropathologic verification of CreutzfeldtJakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenic implications? Neurology 1986;36:932-936.
20. Croxson M, Brown P, Synek B, et al. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand. Neurology 1988;38:1128-1130.
21. Marzewski DJ, Towfighi J, Harrington MG, Merril CR, Brown P. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case. Neurology 1988;38:1131-1133.
22. New MI, Brown P, Temeck JW, Owens C, Hedley-Whyte ET, Richardson EP. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient. Neurology 1988;38:1133-1134.
23. Macario ME, Vaisman M, Buescu A, Neto VM, Araujo HMM, Chagas C. Pituitary growth hormone and Creutzfeldt-Jakob disease [letter]. BMJ 1991;302:1149.
24. Fradkin JE, Schonberger LB, Mills JL, et al. CreutzfeldtJakob disease in pituitary growth hormone recipients in the United States. JAMA 1991;265:880-884.
25. Buchanan CR, Preece MA, Milner RDG. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 1991; 302:824-828.
26. Billette de Villemeur T, Beauvais P, Gourmelen M, Richardet JM. Creutzfeldt-Jakob disease in children treated with growth hormone. Lancet 1991;337:864-865.
27. Billette de Villemeur T, Gourmelen M, Beauvais P, et al. Maladie de Creutzfeldt-Jakob chez quatre enfants traités par hormone de croissance. Rev Neurol (Paris) 1992;148:328-334.
28. Delisle MB, Fabre N, Rochiccioli P, Doerr-Schott J, Rumeau JL, Bes A. Maladie de Creutzfeldt-Jakob après traitement par l'hormone de croissance extractive humaine: étude clinicopathologique. Rev Neurol (Paris) 1993;149:524-527.
29. Labauge P, Pages M, Blard JM, Châtelain J, Laplanche JL. Valine homozygous 129 PrP genotype in a French growthhormone-related Creutzfeldt-Jakob disease patient [letter]. Neurology 1993;43:447.
30. Billette de Villemeur T, Gelot A, Deslys JP, et al. latrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: pathological findings. Neuropathol Appl Neurobiol 1994; 20:111-117.
31. Masson C, Delalande I, Deslys JP, et al. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype. Neurology 1994;44:179.
32. Job JC, Maillard F, Goujard J. Epidemiologic survey of patients treated with growth hormone in France in the period 1959-1990: preliminary results. Horm Res 1992;38(suppl 1): 35-43.
33. Brown P, Coker-Vann M, Franko M, Asher DM, Gibbs CJ, Gajdusek DC. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med 1986;314:547-551.
34. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed: DSM-IV. Washington, DC: American Psychiatric Association, 1994.
35. Deslys JP, Lasmezas C, Dormont D. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet 1994; 43:3848-3849.
36. Brown P, Cathala F, Sadowsky D, Gajdusek DC. CreutzfeldtJakob disease in France. II. Clinical characteristics of 124 consecutive verified cases during the decade 1968-1977. Ann Neurol 1979;6:430-437.
37. Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J. Sporadic Creutzfeldt-Jakob disease in an 18-year-old in the UK. Lancet 1995;346:1155-1156.
38. Britton TC, Al-Sarraj S, Shaw C, Gajdusek DC, Campbell T, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 16-yearold in the UK Lancet 1995;346:1155.
39. Brown P, Gibbs CJ JR, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-529.
40. Monari L, Chen SG, Brown P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sei USA 1994;91:2839-2842.
41. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of world literature. Neurology 1987;37:895-904.
42. Frasier SD, Foley TP. Creutzfeldt-Jakob disease in recipients of pituitary hormones. J Clin Endocrinol Metab 1994;78:1277-1279.
43. Adlard P, Preece MA. Safety of pituitary growth hormone. Lancet 1994;344:612-613.
44. Deslys JP, Marce D, Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994;75:23-27.
45. Collinge J, Palmer MS, Dryken AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441-1442.
46. Dickinson AG, Meikle VMH, Fraser H. Identification of a gene which controls the incubation period of same strains of scrapie agent in mice. J Comp Pathol 1968;78:293-299.
47. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79-90.
48. Anonyme. La maladie de Creutzfeldt-Jakob iatrogène provoquée par l'administration d'hormone de croissance extractive [editorial]. Rev Neurol (Paris) 1993;149:515-516.
49. Billette de Villemeur T, Agid Y. La maladie de CreutzfeldtJakob iatrogène: Quelles sont les précautions àprendre pour prévenir la contamination neurochirurgicale [editorial]? Neurochir 1995;41:l-2.
50. McGreevy Steelman V. Creutzfeldt-Jakob disease: recommendations for infection control. Am J Infect Control 1994;22:312-318.
51. Farrington M. Use of surgical instruments in CreutzfeldtJakob disease. Lancet 1995;345:194.